Often referred to as the “mother of all cannabinoids,” Cannabigerol (CBG) is the non-psychoactive precursor from which other major cannabinoids like CBD and THC are synthesized. While found in lower concentrations in most hemp strains, CBG is rapidly gaining recognition for its powerful therapeutic potential. It’s particularly promising for pain relief and inflammation, with studies suggesting that CBG interacts with CB1 and CB2 receptors as well as TRP channels and inflammatory enzymes like COX-2.

 

A review in Future Medicinal Chemistry highlighted CBG’s anti-inflammatory properties and potential as a novel pain management compound. CBG also supports focus, mental clarity, and mood by influencing dopamine and serotonin activity. A 2018 study in Frontiers in Pharmacology demonstrated CBG’s neuroprotective effects in models of Huntington’s disease. Additional benefits include antibacterial action and support for digestive and urinary tract health.

 

CBG is commonly used in isolate, broad-spectrum, and full-spectrum formulas to promote cognitive performance, comfort, and whole-body wellness.